首页 › 肺癌 › 宾夕法尼亚州

宾夕法尼亚州的肺癌临床试验

宾夕法尼亚州有 57 项针对肺癌的研究正在招募参与者。

宾夕法尼亚州的城市

官方研究文本（英文）

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lehigh Valley Hospital-Cedar Crest, Allentown
UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
以及另外 53 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

招募中1/2 期

12 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
IRMC Cancer Center, Indiana
UPMC Hillman Cancer Center - New Castle, New Castle
以及另外 2 项

招募中

18 岁及以上 · 所有性别 · 更新于 2026年10月2日 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
以及另外 7 项

招募中观察性研究欢迎健康志愿者

40 至 75 岁 · 所有性别 · 更新于 2026年10月2日 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Bryn Mawr Hospital, Bryn Mawr
Penn State Milton S Hershey Medical Center, Hershey
Riddle Memorial Hospital, Media
以及另外 6 项

招募中3 期

70 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
以及另外 12 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT04181060

Empathic Communication Skills (ECS) Training

University of Pennsylvania (Data Collection Only), Philadelphia
Fox Chase Cancer Center (Data Collection Only), Philadelphia

招募中欢迎健康志愿者

18 至 100 岁 · 所有性别 · 更新于 2026年10月1日 · NCT05456841

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
以及另外 14 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年10月1日 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Alliance Cancer Specialists, Sellersville

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月30日 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Penn State Milton S. Hershey Medical Center, Hershey

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT06881784

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT06312137

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Alliance Cancer Specialists - Media, Media
Guthrie Medical Group, Sayre

招募中3 期

18 至 100 岁 · 所有性别 · 更新于 2026年9月25日 · NCT05920356

A Registry for People With Lung Cancer

Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh

招募中观察性研究

18 岁及以上 · 所有性别 · 更新于 2026年9月24日 · NCT06424327

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Pittsburgh

招募中2 期

18 至 95 岁 · 所有性别 · 更新于 2026年9月23日 · NCT05061550

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Hospital of the University of Pennsylvania, Philadelphia
West Penn Allegheny Health, Pittsburgh

招募中2/3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年9月17日 · NCT06287775

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

St. Luke's University Health Network, Bethlehem
Allegheny Cancer Center, Pittsburgh
Reading Hospital - McGlinn Cancer Institute, West Reading

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Alliance Cancer Specialists, PC, Horsham
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年9月8日 · NCT06119581